Samer Ezziddin

42PUBLICATIONS
28CO-AUTHORS
Radiation therapyContext learningMedical microbiology not elsewhere classifiedPredictive and prognostic markersVeterinary diagnosis and diagnostics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jul 07, 2026
Real-world evaluation of [177Lu]Lu-PSMA-617 RLT in post-taxane mCRPC: feasibility and safety of individualized treatment in a challenging cohort.

|Jun 25, 2026
Automated PROMISE V2 Scoring from PSMA PET/CT Reports Using Large Language Models: A Comparative Evaluation of Prompt Design and Model Performance.

|May 04, 2026
Outcome and Safety of Radioligand Therapy With [ 161 Tb]Tb-PSMA-617 After Re-Progression in mCRPC Patients Previously Treated With [ 177 Lu]Lu-PSMA-617.

|Nov 27, 2025
Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting.

Florian Rosar, Fadi Khreish, Caroline Burgard

|Jun 05, 2025
Novel 64 Cu-labeled Trimeric PSMA Ligand Unequivocally Identifies Local Recurrence of Prostate Cancer Ambiguously Imaged by 18 F-DCFPyL PSMA PET/CT.

Mark Bartholomä, Florian Rosar, Caroline Burgard

|May 13, 2025
PSMA Radioligand Therapy in Advanced Age: Insights From an 85y+ mCRPC Patient Cohort.

Moritz B Bastian, Benedikt Wörl, Arne Blickle

Pageof 7

Frequent Collaborators

23 joint publications

Florian Rosar

18 joint publications

Caroline Burgard

12 joint publications

Fadi Khreish

10 joint publications

Moritz B Bastian